Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21
Phase 32

Trial Status

Completed4
Terminated1
Other1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT04818086Phase 1/2Completed
Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder
AnalgesicsDrug InteractionOpioid Use Disorder
PrincipalinvestigatorStart date: 2021-05-03
NCT03818399Phase 3Terminated
Virginia Opioid Overdose Treatment InitiatVE
Opioid Use Disorder
PrincipalinvestigatorStart date: 2019-01-04
NCT03489161Early Phase 1Completed
Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
Drug OverdoseOpioid WithdrawalOpioid-use Disorder
PrincipalinvestigatorStart date: 2018-08-01
NCT03143855Phase 1Completed
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
Opioid AbuseOpioid DependenceOpioid Use+1 more
PrincipalinvestigatorStart date: 2017-01-30
NCT04523792Phase 3Withdrawn
Virginia Opioid Treatment-Emergency Department
Opioid Use Disorder
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zev Schuman-Olivier, MD

Cambridge Health Alliance

Related
14 trials

Shared therapeutic areas:

Opioid Use DisorderOpioid-Related Disorders
Similarity Score7%

Rajita Sinha, PhD

Yale University

Related
11 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score7%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score7%

Colleen A Hanlon, PhD

Medical University of South Carolina

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score7%

David Fiellin, MD

Yale University

Related
7 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score7%

Frederick L Altice, MD

Yale University

Related
8 trials

Shared therapeutic areas:

Opioid Use DisorderOpioid Use

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score7%

Jason Doctor, PhD

University of Southern California

Related
8 trials

Shared therapeutic areas:

Opioid AbuseOpioid Use
Similarity Score7%

Madhukar Trivedi, MD

University of Texas Southwestern Medical Center

Related
13 trials

Shared therapeutic areas:

Cocaine Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score3%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Drug Interactions
Similarity Score3%

Hakan Gürpınar

Humanis Saglık

Related
9 trials

Shared therapeutic areas:

Analgesics
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT04818086Phase 1/2PrincipalInvestigator

Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder

AnalgesicsDrug InteractionOpioid Use Disorder
Completed
NCT03818399Phase 3PrincipalInvestigator

Virginia Opioid Overdose Treatment InitiatVE

Opioid Use Disorder
Terminated
NCT03489161Early Phase 1PrincipalInvestigator

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

Drug OverdoseOpioid WithdrawalOpioid-use Disorder
Completed
NCT03143855Phase 1PrincipalInvestigator

Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder

Opioid AbuseOpioid DependenceOpioid Use+1 more
Completed
NCT02537873Phase 1PrincipalInvestigator

Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder

Cocaine Use Disorder
Completed
NCT04523792Phase 3PrincipalInvestigator

Virginia Opioid Treatment-Emergency Department

Opioid Use Disorder
Withdrawn

All 6 trials loaded